Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Author(s)
- Haanen, J; Obeid, M; Spain, L; Carbonnel, F; Wang, Y; Robert, C; Lyon, AR; Wick, W; Kostine, M; Peters, S; Jordan, K; Larkin, J; ESMO Guidelines Committee;
- Details
- Publication Year 2022-12,Volume 33,Issue #12,Page 1217-1238
- Journal Title
- Annals of Oncology
- Publication Type
- Guideline
- Keywords
- Humans; Follow-Up Studies; *Immunotherapy/adverse effects; *Immunologic Factors; ESMO Clinical Practice Guideline; immunotherapy; side-effects; toxicity; treatment
- Department(s)
- Medical Oncology
- PubMed ID
- 36270461
- Publisher's Version
- https://doi.org/10.1016/j.annonc.2022.10.001
- Open Access at Publisher's Site
https://doi.org/10.1016/j.annonc.2022.10.001- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-11-01 04:13:40
Last Modified: 2024-11-01 04:19:47